This Histopathology Core B will be housed at University of Chicago. Core B will be responsible for the histopathological analysis of muscle tissue. The hallmark pathological features of muscular dystrophy include: variation in fiber size, central nucleation, increased extracellular matrix deposition, fatty infiltration, immune cell infiltration, apoptosis, necrosis, calcification and regeneration. Each of these features can be measured either by histopathological examination or by assays that can be performed on an entire muscle. A cardinal feature of the muscular dystrophies is that the pathological findings are not uniformly distributed across a muscle group. To circumvent sampling error that can complicate histopathological analysis, this Core has established quantitative assays that can be used to reflect the process across the entire muscle that is being assayed. This core will provide histopathological examination of the animals generated in the Projects. Quantitative assays across muscle groups will also be performed. Each project will use Core B. The Core's function and output will be overseen by an experienced neuropathologist who has a special interest in muscular dystrophy. The Core will be housed in the Histopathology Core Facility within the Molecular Cardiology/Institute for Cardiovascular Research at the University of Chicago. This facility, established in the early 1990's, has had benefit of stable technical direction and oversight. With the increase in samples to be processed from each of the three Projects in this program, the technical director will supervise the training of new technical staff who will then be responsible for the processing of samples related to the Program.
In muscular dystrophy, the muscle appears abnormal and displays increased fibrosis, cell disruption, regeneration and other features. These features will be uniformly assessed by this Core facility to ensure that comparisons can be made from multiple experiments. Consistent and even measurements of muscle pathology are a necessary component for each of the Projects in this Program.
|Molkentin, Jeffery D (2014) Letter by Molkentin regarding article, "The absence of evidence is not evidence of absence: the pitfalls of Cre Knock-Ins in the c-Kit Locus". Circ Res 115:e21-3|
|Rainer, Peter P; Hao, Scarlett; Vanhoutte, Davy et al. (2014) Cardiomyocyte-specific transforming growth factor ? suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction. Circ Res 114:1246-57|
|Swaggart, Kayleigh A; McNally, Elizabeth M (2014) Modifiers of heart and muscle function: where genetics meets physiology. Exp Physiol 99:621-6|
|Davis, Jennifer; Molkentin, Jeffery D (2014) Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol 70:9-18|
|Fahrenbach, John P; Andrade, Jorge; McNally, Elizabeth M (2014) The CO-Regulation Database (CORD): a tool to identify coordinately expressed genes. PLoS One 9:e90408|
|Puckelwartz, Megan J; Pesce, Lorenzo L; Nelakuditi, Viswateja et al. (2014) Supercomputing for the parallelization of whole genome analysis. Bioinformatics 30:1508-13|
|Swaggart, Kayleigh A; Demonbreun, Alexis R; Vo, Andy H et al. (2014) Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair. Proc Natl Acad Sci U S A 111:6004-9|
|Kwong, J Q; Davis, J; Baines, C P et al. (2014) Genetic deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 21:1209-17|
|Demonbreun, Alexis R; McNally, Elizabeth M (2014) Dynamin 2 the rescue for centronuclear myopathy. J Clin Invest 124:976-8|
|Golbus, Jessica R; Puckelwartz, Megan J; Dellefave-Castillo, Lisa et al. (2014) Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet 7:751-9|
Showing the most recent 10 out of 14 publications